ICG
ABBV icon

InterOcean Capital Group’s AbbVie ABBV Stock Holding History

InterOcean Capital Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$12.6M Sell
68,921
-195
-0.3% -$33.6K 0.3% 76
2023
Q4 		$10.7M Buy
69,116
+679
+1% +$99K 0.29% 77
2023
Q3 		$10.2M Buy
68,437
+962
+1% +$141K 0.31% 69
2023
Q2 		$9.09M Sell
67,475
-2,082
-3% -$305K 0.29% 68
2023
Q1 		$11.1M Buy
69,557
+3,115
+5% +$476K 0.37% 61
2022
Q4 		$10.7M Sell
66,442
-1,320
-2% -$202K 0.39% 59
2022
Q3 		$9.09M Buy
67,762
+47,276
+231% +$6.78M 0.37% 60
2022
Q2 		$3.14M Buy
20,486
+9,376
+84% +$1.43M 0.13% 95
2022
Q1 		$1.8M Buy
11,110
+705
+7% +$102K 0.08% 97
2021
Q4 		$1.41M Buy
10,405
+1,713
+20% +$202K 0.06% 107
2021
Q3 		$938K Buy
8,692
+508
+6% +$58K 0.05% 121
2021
Q2 		$922K Buy
8,184
+359
+5% +$40.4K 0.05% 124
2021
Q1 		$847K Sell
7,825
-178
-2% -$19K 0.05% 121
2020
Q4 		$857K Buy
+8,003
New +$769K 0.05% 106

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

InterOcean Capital Group's ABBV Position: Q1 2024 in Review

InterOcean Capital Group reduced its AbbVie (ABBV) stake by 0.28% in Q1 2024, selling an estimated $33.6K and leaving 68,921 shares worth $12.6M. The position accounts for 0.3% of the portfolio, ranked #76.

InterOcean Capital Group first reported a position in ABBV in Q4 2020 and has held it in 14 quarters since. 3,380 funds tracked by Wall St. Rank hold ABBV as of Q1 2024.

  • InterOcean Capital Group held 68,921 shares of AbbVie worth $12.6M as of Q1 2024.
  • InterOcean Capital Group sold 195 AbbVie shares in Q1 2024, an estimated $33.6K.
  • AbbVie made up 0.3% of InterOcean Capital Group's portfolio in Q1 2024, its #76 holding.
  • InterOcean Capital Group first reported a position in AbbVie in Q4 2020 and has held it in 14 quarters since.
  • 3,380 funds tracked by Wall St. Rank held AbbVie as of Q1 2024.

Based on InterOcean Capital Group's 13F filing for Q1 2024, filed 13 May 2024.